환자 모니터링 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Patient Monitoring Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,356,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,760,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,569,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

환자 모니터링 기기 시장 개요

환자 모니터링 기기 세계 시장 규모는 2024년에 503억 6,000만 달러로 평가되었습니다. 2033년에는 1,182억 1,000만 달러에 달하고, 2025-2033년10.21%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 산업의 확대는 혈압, 체온, 혈중 산소포화도 등 다양한 생체 데이터를 측정, 기록, 표시하는 모니터링 기기에 대한 수요 증가에 기인합니다.

노인 인구 증가, 심혈관 질환, 당뇨병, 호흡기 질환 등 만성 질환의 유병률 증가, 지속적인 모니터링의 필요성 증가는 시장 성장을 뒷받침하는 주요 요인입니다. 예를 들어, 세계보건기구(WHO)는 2030년까지 전 세계 인구 6명 중 1명이 60세 이상이 될 것으로 예상하고 있으며, 이는 적시에 개입하고 원격 치료를 가능하게 하는 기술에 대한 수요를 증폭시키고 있습니다. 원격의료와 원격 환자 모니터링 프로그램 도입이 증가하는 배경에는 의료비 압박과 인력 부족이 있습니다. 예를 들어, AMA 디지털 헬스케어 2022 설문 조사에 따르면, 의사의 93%가 디지털 도구를 유용하게 여기고 있으며, 원격 환자 모니터링(RPM)의 활용률은 2016년 이후 두 배 이상 증가한 30%에 이르렀다고 합니다. 이러한 채택 증가는 만성질환 관리, 급성기 이후 회복, 예방의학으로 이어지는 모니터링 기기에 대한 임상의들의 강한 신뢰를 반영합니다.

소형화, 배터리 수명, 무선 연결 기술 개발이 시장을 더욱 견인하고 있습니다. 예를 들어, FDA는 성인 당뇨병 환자를 위한 Dexcom의 15일간 연속 혈당 모니터링(CGM) 시스템 G7을 승인했습니다. 이 차세대 장치는 최대 15.5일의 착용 시간, MARD8.0%의 정확도 향상, 12시간의 유예기간을 제공하여 현재 미국 시장에서 판매되고 있는 CGM 중 가장 오래 지속되고 가장 높은 정확도를 제공합니다. 마찬가지로, 메드트로닉은 2022년 9월, 블루투스 연결 기능을 갖춘 삽입형 심장 모니터 LINQ II의 FDA 승인을 발표했습니다. 이러한 기술 혁신은 기기의 설계와 연결성을 지속적으로 개선하여 원격 모니터링 기능을 강화하고 적극적인 만성 질환 관리를 지원한다는 점을 강조하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 환자 모니터링 기기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 침투 및 성장 전망 매핑
• 제품 파이프라인 분석(스테이지 별)
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 산업 과제 분석
  • 산업 기회 분석
• 환자 모니터링 기기 : 시장 분석 툴
  • 산업 분석 - Porter의 Five Forces 분석
  • PESTEL 분석
• 주요 거래와 전략적 제휴 분석
• 이용 사례
• 기술 진보

제4장 환자 모니터링 기기 시장 : 제품별, 부문 분석, 2021-2033년

• 부문 대시보드
• 제품 시장 점유율 분석, 2021년과 2033년
• 세계의 환자 모니터링 기기 시장(제품별, 2021-2033년)
• 시장 규모와 예측과 동향 분석, 2021-2033년

제5장 환자 모니터링 기기 시장 부문 분석, 최종 용도별, 2021-2033년

• 정의와 범위
• 최종 용도 시장 점유율 분석, 2024년과 2033년
• 부문 대시보드
• 세계의 환자 모니터링 기기 시장(최종 용도별, 2021-2033년)
• 병원
  • 시장 매출 추정과 예측, 2021-2033년
• 외래수술센터(ASC)
  • 시장 매출 추정과 예측, 2021-2033년
• 홈케어
  • 시장 매출 추정과 예측, 2021-2033년
• 기타
  • 시장 매출 추정과 예측, 2021-2033년

제6장 환자 모니터링 기기 시장 부문 분석, 지역별, 2021-2033년

• 지역별 시장 점유율 분석, 2024년과 2033년
• 지역별 시장 대시보드
• 지역 시장 스냅숏
• 환자 모니터링 기기 시장 점유율(지역별, 2024년과 2033년)
• 북미
  • 북미의 환자 모니터링 기기 시장, 2021-2033년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 환자 모니터링 기기 시장, 2021-2033년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 기업 분류
• 기업의 시장 점유율 분석, 2024년(%)
• 기업 개요
  • Bosch
  • BIoTronik
  • Welch Allyn
  • Koninklijke Philips NV
  • GE Healthcare
  • Medtronic
  • MASIMO CORPORATION
  • Smiths Medical
  • OMRON Corporation
  • Mindray Medical India Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd
  • Dragerwerk AG & Co. KGaA
  • NIHON KOHDEN CORPORATION
  • Natus Medical

LSH

영문 목차

영문목차

Patient Monitoring Devices Market Summary

The global patient monitoring devices market size was valued at USD 50.36 billion in 2024 and is expected to reach USD 118.21 billion by 2033, growing at a CAGR of 10.21% from 2025 to 2033. The expansion of the industry can be attributed to the increasing demand for monitoring devices that measure, record, and display various biometric data, including blood pressure, temperature, and blood oxygen saturation levels.

The growing geriatric population, rising prevalence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders, and the increasing need for continuous monitoring are key drivers supporting market growth. For instance, the World Health Organization estimates that by 2030, one in six people globally will be 60 years or older, amplifying the demand for technologies that enable timely intervention and remote care. Rising adoption of telehealth and remote patient monitoring programs is driven by healthcare cost pressures and staffing shortages. For instance, the AMA Digital Health Care 2022 study highlighted that 93% of physicians find digital tools beneficial, with remote patient monitoring (RPM) usage more than doubling to 30% since 2016. This growing adoption reflects strong clinician confidence in connected monitoring devices for managing chronic diseases, post-acute recovery, and preventive care.

Technological developments in miniaturization, battery life, and wireless connectivity are further driving the market. For instance, in The FDA has cleared Dexcom's G7 15-Day Continuous Glucose Monitoring (CGM) system for adults with diabetes. This next-generation device offers up to 15.5 days of wear time, improved accuracy with an 8.0% MARD, and a 12-hour grace period, making it the longest-lasting and most precise CGM currently available in the U.S. market. Similarly, in September 2022, Medtronic announced the FDA clearance of its LINQ II insertable cardiac monitor with Bluetooth connectivity, offering real-time arrhythmia data transmission to physicians and facilitating earlier intervention. These innovations highlight how continuous improvements in device design and connectivity are enhancing remote monitoring capabilities and supporting proactive chronic disease management.

Global Patient Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global patient monitoring devices market report based on product, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Blood Glucose Monitoring Systems
  • Self-monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
• Cardiac Monitoring Devices
  • ECG Devices
  • Implantable Loop Recorders
  • Event Monitors
  • Mobile Cardiac Telemetry Monitors
  • Smart/Wearable ECG Monitors
• Multi-parameter Monitoring Devices.
  • Low-acuity Monitoring Devices
  • Mid-acuity Monitoring Devices
  • High-acuity Monitoring Devices
• Respiratory Monitoring Devices
  • Pulse Oximeters
  • Spirometers
  • Capnographs
  • Peak Flow Meters
• Temperature Monitoring Devices
  • Handheld Temperature Monitoring Devices
  • Table-top Temperature Monitoring Devices
  • Wearable Continuous Monitoring Devices
  • Invasive Temperature Monitoring Devices
  • Smart Temperature Monitoring Devices
• Hemodynamic/Pressure Monitoring Devices
  • Hemodynamic Monitors
  • Blood Pressure Monitors
  • Disposables
• Fetal & Neonatal Monitoring Devices
  • Fetal Monitoring Devices
  • Neonatal Monitoring Devices
• Neuromonitoring Devices
  • Electroencephalograph Machines
  • Electromyography Machines
  • Cerebral Oximeters
  • Intracranial Pressure Monitors
  • Magnetoencephalograph Machines
  • Transcranial Doppler Machines
• Wearable Drug Delivery Systems
• Weight Monitoring Devices
  • Digital
  • Analog
• Other Patient Monitoring Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Patient Monitoring Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Product Pipeline Analysis, by Stage
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
  • 3.4.2. Market restraint analysis
  • 3.4.3. Industry challenges Analysis
  • 3.4.4. Industry Opportunity Analysis
• 3.5. Patient Monitoring Devices: Market Analysis Tools
  • 3.5.1. Industry analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat from new entrants
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Environmental landscape
    • 3.5.2.3. Social landscape
    • 3.5.2.4. Technology landscape
    • 3.5.2.5. Legal landscape
• 3.6. Major deals & strategic alliances analysis
• 3.7. Case Studies
• 3.8. Technological Advancement

Chapter 4. Patient Monitoring Devices Market: Segment Analysis, by Product, 2021 - 2033 (USD Million)

• 4.1. Segment Dashboard
• 4.2. Product Market Share Analysis, 2021 & 2033
• 4.3. Global Patient Monitoring Devices Market, by Product, 2021 to 2033
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
  • 4.4.1. Blood Glucose Monitoring Systems
    • 4.4.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.2. Self-monitoring blood glucose systems
      • 4.4.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.3. Continuous Glucose Monitoring System
      • 4.4.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Cardiac Monitoring Devices
    • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. ECG Devices
      • 4.4.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Implantable Loop Records
      • 4.4.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.4. Event Monitors
      • 4.4.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.5. Mobile Cardiac Telemetry Monitors
      • 4.4.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.6. Smart/Wearable ECG Monitors
      • 4.4.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Multi-parameter Monitoring Devices.
    • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Low-acuity Monitoring Devices
      • 4.4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Mid-acuity Monitoring Devices
      • 4.4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. High-acuity Monitoring Devices
      • 4.4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Respiratory Monitoring Devices
    • 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.2. Pulse Oximeters
      • 4.4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.3. Spirometer
      • 4.4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.4. Capnographs
      • 4.4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.5. Peak Flow Meters
      • 4.4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Temperature Monitoring Devices
    • 4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.2. Handheld Temperature Monitoring Devices
      • 4.4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.3. Table-top Temperature Monitoring Devices
      • 4.4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.4. Wearable Continuous Monitoring Devices
      • 4.4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.5. Invasive Temperature Monitoring Devices
      • 4.4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Smart Temperature Monitoring Devices
    • 4.4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.7. Hemodynamic/ Pressure Monitoring Devices
    • 4.4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.2. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.3. Hemodynamic Monitoring Devices
      • 4.4.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.4. Blood Pressure Monitors
      • 4.4.7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.7.5. Disposable
      • 4.4.7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.8. Fetal & Neonatal Monitoring Devices
    • 4.4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.8.2. Fetal Monitoring Devices
      • 4.4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.8.3. Neonatal Monitoring Devices
      • 4.4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.9. Neuromonitoring Devices
    • 4.4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.2. Electroencephalograph Machines
      • 4.4.9.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.3. Electromyography Machines
      • 4.4.9.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.4. Cerebral Oximeters
      • 4.4.9.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.5. Intracranial Pressure Monitors
      • 4.4.9.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.6. Magnetoencephalograph Machines
      • 4.4.9.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.9.7. Transcranial Doppler Machines
      • 4.4.9.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.10. Weight Monitoring Devices
    • 4.4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.10.2. Digital
      • 4.4.10.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.10.3. Analog
      • 4.4.10.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.11. Wearable Drug Delivery Systems
    • 4.4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.12. Other Patient Monitoring Devices
    • 4.4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Patient Monitoring Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End use Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Patient Monitoring Devices Market, by End Use, 2021 to 2033
• 5.5. Hospitals
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Ambulatory Surgery Centers
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Home Care Settings
  • 5.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Patient Monitoring Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Patient Monitoring Devices Market Share by Region, 2024 & 2033:
• 6.5. North America
  • 6.5.1. North America Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Scenario
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Scenario
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Scenario
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Scenario
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Scenario
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Scenario
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Scenario
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Scenario
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Scenario
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Scenario
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Scenario
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Scenario
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Scenario
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. China Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Scenario
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Scenario
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Scenario
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Scenario
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Scenario
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Scenario
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Scenario
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Scenario
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Scenario
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Scenario
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait Patient Monitoring Devices Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Share Analysis, 2024 (%)
• 7.4. Company Profiles
  • 7.4.1. Bosch
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Biotronik
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Welch Allyn
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Koninklijke Philips N.V.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. GE Healthcare
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Medtronic
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. MASIMO CORPORATION
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Smiths Medical
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. OMRON Corporation
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Mindray Medical India Pvt. Ltd.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. F. Hoffmann-La Roche Ltd
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Dragerwerk AG & Co. KGaA
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. NIHON KOHDEN CORPORATION
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Natus Medical
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives

관련자료